ADVANCING INNOVATION IN DERMATOLOGY INC
Balance Sheet
Fiscal Year Start:
Jan 1
Assets in 2024 (Year End)
$1,971,359
Cash & Equivalents
93%
Prepaid Expenses
6%
Other Assets
<1%
Receivables (Non-Related)
0%
Related-Party Receivables
0%
Inventories
0%
Investments
0%
Property, Plant, & Equipment (net)
0%
Liabilities in 2024 (Year End)
$273,400
Deferred Revenue
82%
Payables & Accruals
11%
Other Liabilities
7%
Grants Payable
0%
Tax-Exempt Bond Liabilities
0%
Custodial & Escrow Liabilities
0%
Notes Payable / Debt (Non-Related)
0%
Related-Party Payables
0%
Assets
2023
2024
Change
Cash & Equivalents
$1,878,688
$1,839,755
-2%
Receivables (Non-Related)
-
-
-
Related-Party Receivables
-
-
-
Inventories
-
-
-
Prepaid Expenses
$170,679
$128,043
-25%
Investments
-
-
-
Property, Plant, & Equipment (net)
-
-
-
Other Assets
$1,963
$3,561
+81%
Total Assets
$2,051,330
$1,971,359
-4%
Liabilities
2023
2024
Change
Payables & Accruals
$31,214
$30,706
-2%
Grants Payable
-
-
-
Deferred Revenue
$383,350
$223,994
-42%
Tax-Exempt Bond Liabilities
-
-
-
Custodial & Escrow Liabilities
-
-
-
Notes Payable / Debt (Non-Related)
-
-
-
Related-Party Payables
-
-
-
Other Liabilities
$6,923
$18,700
+170%
Total Liabilities
$421,487
$273,400
-35%
Net assets
2023
2024
Change
Restricted Net Assets
$469,183
$468,902
0%
Unrestricted Net Assets
$1,160,660
$1,229,057
+6%
Net assets
2023
2024
Change
Net assets
+$1,629,843
+$1,697,959
+4%
Copyright 2026. All rights reserved to Chario Inc. (d.b.a. Impala)